Skip to main content

No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.

Publication ,  Journal Article
Lancaster, JM; Wenham, RM; Halabi, S; Calingaert, B; Marks, JR; Moorman, PG; Bentley, RC; Berchuck, A; Schildkraut, JM
Published in: Cancer Epidemiol Biomarkers Prev
March 2003

Duke Scholars

Published In

Cancer Epidemiol Biomarkers Prev

ISSN

1055-9965

Publication Date

March 2003

Volume

12

Issue

3

Start / End Page

226 / 227

Location

United States

Related Subject Headings

  • Risk
  • Receptors, Progesterone
  • Polymorphism, Genetic
  • Ovarian Neoplasms
  • North Carolina
  • Middle Aged
  • Humans
  • Genotype
  • Female
  • Epidemiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lancaster, J. M., Wenham, R. M., Halabi, S., Calingaert, B., Marks, J. R., Moorman, P. G., … Schildkraut, J. M. (2003). No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina. Cancer Epidemiol Biomarkers Prev, 12(3), 226–227.
Lancaster, Johnathan M., Robert M. Wenham, Susan Halabi, Brian Calingaert, Jeffrey R. Marks, Patricia G. Moorman, Rex C. Bentley, Andrew Berchuck, and Joellen M. Schildkraut. “No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.Cancer Epidemiol Biomarkers Prev 12, no. 3 (March 2003): 226–27.
Lancaster JM, Wenham RM, Halabi S, Calingaert B, Marks JR, Moorman PG, et al. No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina. Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):226–7.
Lancaster, Johnathan M., et al. “No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.Cancer Epidemiol Biomarkers Prev, vol. 12, no. 3, Mar. 2003, pp. 226–27.
Lancaster JM, Wenham RM, Halabi S, Calingaert B, Marks JR, Moorman PG, Bentley RC, Berchuck A, Schildkraut JM. No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina. Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):226–227.

Published In

Cancer Epidemiol Biomarkers Prev

ISSN

1055-9965

Publication Date

March 2003

Volume

12

Issue

3

Start / End Page

226 / 227

Location

United States

Related Subject Headings

  • Risk
  • Receptors, Progesterone
  • Polymorphism, Genetic
  • Ovarian Neoplasms
  • North Carolina
  • Middle Aged
  • Humans
  • Genotype
  • Female
  • Epidemiology